208 related articles for article (PubMed ID: 38049665)
1. Noncoding mutations cause super-enhancer retargeting resulting in protein synthesis dysregulation during B cell lymphoma progression.
Leeman-Neill RJ; Song D; Bizarro J; Wacheul L; Rothschild G; Singh S; Yang Y; Sarode AY; Gollapalli K; Wu L; Zhang W; Chen Y; Lauring MC; Whisenant DE; Bhavsar S; Lim J; Swerdlow SH; Bhagat G; Zhao Q; Berchowitz LE; Lafontaine DLJ; Wang J; Basu U
Nat Genet; 2023 Dec; 55(12):2160-2174. PubMed ID: 38049665
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological and genomic analysis of double-hit follicular lymphoma: comparison with high-grade B-cell lymphoma with MYC and BCL2 and/or BCL6 rearrangements.
Miyaoka M; Kikuti YY; Carreras J; Ikoma H; Hiraiwa S; Ichiki A; Kojima M; Ando K; Yokose T; Sakai R; Hoshikawa M; Tomita N; Miura I; Takata K; Yoshino T; Takizawa J; Bea S; Campo E; Nakamura N
Mod Pathol; 2018 Feb; 31(2):313-326. PubMed ID: 28984304
[TBL] [Abstract][Full Text] [Related]
3. Detection of Enhancer-Associated Rearrangements Reveals Mechanisms of Oncogene Dysregulation in B-cell Lymphoma.
Ryan RJ; Drier Y; Whitton H; Cotton MJ; Kaur J; Issner R; Gillespie S; Epstein CB; Nardi V; Sohani AR; Hochberg EP; Bernstein BE
Cancer Discov; 2015 Oct; 5(10):1058-71. PubMed ID: 26229090
[TBL] [Abstract][Full Text] [Related]
4. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene.
Lossos IS; Levy R
Blood; 2000 Jul; 96(2):635-9. PubMed ID: 10887128
[TBL] [Abstract][Full Text] [Related]
5. Multiplex sequencing for EZH2, CD79B, and MYD88 mutations using archival cytospin preparations from B-cell non-Hodgkin lymphoma aspirates previously tested for MYC rearrangement and IGH/BCL2 translocation.
Santos Gda C; Saieg MA; Ko HM; Geddie WR; Boerner SL; Craddock KJ; Crump M; Bailey D
Cancer Cytopathol; 2015 Jul; 123(7):413-20. PubMed ID: 25807917
[TBL] [Abstract][Full Text] [Related]
6. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
7. Unexpected favorable outcome in a patient with high grade B-cell lymphoma with abnormalities of MYC, BCL6 and BCL2 loci.
Adams T; Fuchs D; Shadoan PK; Johnstone L; Lau BM; McGhan L; Anwer F; Al-Kateb H
Cancer Genet; 2018 Apr; 222-223():25-31. PubMed ID: 29666005
[TBL] [Abstract][Full Text] [Related]
8. Double-hit pancreatic B-lymphoblastic lymphoma with a variant translocation t(2;18)(p11;q21).
Yamamoto K; Kawamoto S; Kitao A; Mizutani Y; Inui Y; Yakushijin K; Kajimoto K; Hayashi Y; Matsuoka H; Minami H
Int J Hematol; 2019 Jul; 110(1):107-114. PubMed ID: 30963474
[TBL] [Abstract][Full Text] [Related]
9. Involvement of BCL6 in chromosomal aberrations affecting band 3q27 in B-cell non-Hodgkin lymphoma.
Chaganti SR; Chen W; Parsa N; Offit K; Louie DC; Dalla-Favera R; Chaganti RS
Genes Chromosomes Cancer; 1998 Dec; 23(4):323-7. PubMed ID: 9824205
[TBL] [Abstract][Full Text] [Related]
10. Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3' regulatory region.
Gostissa M; Yan CT; Bianco JM; Cogné M; Pinaud E; Alt FW
Nature; 2009 Dec; 462(7274):803-7. PubMed ID: 20010689
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
12. p53 mutation in B-cell lymphoid neoplasms with reference to oncogene rearrangements associated with chromosomal translocations.
Akasaka T; Muramatsu M; Kadowaki N; Ohno H; Ishizaki K; Yamabe H; Fukuhara S; Okuma M
Jpn J Cancer Res; 1996 Sep; 87(9):930-7. PubMed ID: 8878455
[TBL] [Abstract][Full Text] [Related]
13. Mapping of MYC breakpoints in 8q24 rearrangements involving non-immunoglobulin partners in B-cell lymphomas.
Bertrand P; Bastard C; Maingonnat C; Jardin F; Maisonneuve C; Courel MN; Ruminy P; Picquenot JM; Tilly H
Leukemia; 2007 Mar; 21(3):515-23. PubMed ID: 17230227
[TBL] [Abstract][Full Text] [Related]
14. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
15. New developments in non-Hodgkin lymphoid malignancies.
Ganapathi KA; Brown LE; Prakash S; Bhargava P
Pathology; 2021 Apr; 53(3):349-366. PubMed ID: 33685720
[TBL] [Abstract][Full Text] [Related]
16. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
[TBL] [Abstract][Full Text] [Related]
17. Double-hit and triple-hit lymphomas arising from follicular lymphoma following acquisition of MYC: report of two cases and literature review.
Xu X; Zhang L; Wang Y; Zhang Q; Zhang L; Sun B; Zhang Y
Int J Clin Exp Pathol; 2013; 6(4):788-94. PubMed ID: 23573328
[TBL] [Abstract][Full Text] [Related]
18. B-cell lymphomas with MYC/8q24 rearrangements and IGH@BCL2/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome.
Li S; Lin P; Fayad LE; Lennon PA; Miranda RN; Yin CC; Lin E; Medeiros LJ
Mod Pathol; 2012 Jan; 25(1):145-56. PubMed ID: 22002575
[TBL] [Abstract][Full Text] [Related]
19. High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.
Rosenthal A; Younes A
Blood Rev; 2017 Mar; 31(2):37-42. PubMed ID: 27717585
[TBL] [Abstract][Full Text] [Related]
20. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
